Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

12.26
-0.0100-0.08%
Post-market: 12.260.00000.00%19:38 EDT
Volume:1.12M
Turnover:13.72M
Market Cap:1.99B
PE:556.31
High:12.43
Open:12.30
Low:12.05
Close:12.27
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.77
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:8.24
PE(LYR):276.15

Loading ...

Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021

Dow Jones
·
Jul 15

After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?

TIPRANKS
·
Jul 15

Crinetics Pharmaceuticals (CRNX) Looks Fully Valued As Vertex Agrees $85 Per Share Deal

Simply Wall St.
·
Jul 15

Vertex to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 15

Vertex Minerals lifts gold sales and advances mechanised mining at Reward

TIPRANKS
·
Jul 14

Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14

Vertex Pharmaceuticals is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 14

UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating

MT Newswires Live
·
Jul 13

BMO Capital Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 13

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 11

Crinetics Pharmaceuticals Announces Merger Agreement With Vertex

TIPRANKS
·
Jul 11

Vertex: Buy Rating Reaffirmed as Crinetics Deal Broadens Revenue Base; $575 Price Target Maintained

TIPRANKS
·
Jul 10

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570

MT Newswires Live
·
Jul 10

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Analysts Conflicted on These Healthcare Names: Certara (CERT), Nurix Therapeutics (NRIX) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 08

Jefferies Adjusts Vertex Pharmaceuticals Price Target to $610 From $580

MT Newswires Live
·
Jul 08

Crinetics downgraded to In Line from Outperform at Evercore ISI

TIPRANKS
·
Jul 08

Vertex (VERX) Could Be 28% Undervalued As TD Cowen Backs Its Profit Plan

Simply Wall St.
·
Jul 08

Press Release: Vertex to Announce Second Quarter 2026 Financial Results on August 3rd

Dow Jones
·
Jul 08

Vertex Pharmaceuticals' Acquisition of Crinetics Adds Rare-Disease Drugs, UBS Says

MT Newswires Live
·
Jul 08